Floatz logo

[68ga]ga-nota-rt4

Solid Carcinoma

RenJi HospitalradiopharmaceuticalPhase 2/3Active
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
81/ 100

Competitive context

44 Active assets in the Solid Carcinoma cohort.

Asset / SponsorPhaseRating
Palbociclib
Academic and Community Cancer Research United
Phase 2B
TIPIRACIL
Academic and Community Cancer Research United
Phase 2B
Trifluridine
Academic and Community Cancer Research United
Phase 2B
CIS-DIAMMINEDICHLOROPLATINUM II
National Cancer Institute (NCI)
Phase 1/2B
Binimetinib
Academic and Community Cancer Research United
Phase 2B

View all 50 →

Same molecule, other indications

[68ga]ga-nota-rt4 is also rated in:

urothelial carcinomaDormant
B
Indicative ·
57 / 100
View asset →
nasopharyngeal carcinomaDormant
B
Indicative ·
57 / 100
View asset →
thyroid cancerDormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →